東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Specificity and promiscuity among hi...

McGovern, Susan Lynne.

Linked to FindBook

Google Book

Amazon

博客來

Specificity and promiscuity among hits, leads, and drugs.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Specificity and promiscuity among hits, leads, and drugs./
Author:	McGovern, Susan Lynne.
Description:	230 p.
Notes:	Source: Dissertation Abstracts International, Volume: 64-04, Section: B, page: 1724.
Contained By:	Dissertation Abstracts International64-04B.
Subject:	Chemistry, Biochemistry. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3087941

Specificity and promiscuity among hits, leads, and drugs.
McGovern, Susan Lynne.

Specificity and promiscuity among hits, leads, and drugs. - 230 p.

Source: Dissertation Abstracts International, Volume: 64-04, Section: B, page: 1724.

Thesis (Ph.D.)--Northwestern University, 2003.

Specificity is key to the function of biologically active molecules, including messengers, hormones, and drugs. Perplexingly, many small-molecule enzyme inhibitors show poor specificity. To investigate the origins of inhibitor promiscuity, 110 compounds were studied. These compounds included hits from virtual and high-throughput screening, leads for drug design, and clinically-used drugs. Fifty of these compounds (35 hits, 8 leads, and 7 drugs) were found to inhibit diverse model enzymes, including beta-lactamase, chymotrypsin, dihydrofolate reductase, malate dehydrogenase, and beta-galactosidase. These promiscuous inhibitors acted in a time-dependent manner that was sensitive to enzyme concentration, ionic strength, and albumin. By light scattering and electron microscopy, promiscuous compounds were observed to form spherical particles of 30--1000 nm diameter. Particles were absent from solutions of the 60 non-promiscuous compounds (10 hits, 7 leads, and 43 drugs). Based on these observations, it was hypothesized that the promiscuous compounds formed aggregates in solution, and the aggregates inhibited the model enzymes. To explore the mechanism of aggregate-based inhibition, biophysical and microscopy studies were performed. Co-sedimentation experiments suggested a direct interaction between enzyme and aggregrates; by electron microscopy, enzyme molecules were observed to associate with the surface of aggregates. This interaction was prevented by Triton X-100, which reversed enzyme inhibition by promiscuous compounds but not by specific inhibitors. These studies suggest that inhibition by aggregate-forming promiscuous compounds results from the reversible adsorption of enzyme onto the surface of aggregates, although absorption of enzyme into the aggregate interior cannot be excluded. This dissertation also provides methods for the identification of aggregate-forming promiscuous compounds, which appear to be widespread.Subjects--Topical Terms:

1017722
Chemistry, Biochemistry.

Specificity and promiscuity among hits, leads, and drugs.
LDR:03498nmm 2200301 4500 001 1861348
005 20041111121750.5
008 130614s2003 eng d
035 $a (UnM)AAI3087941
035 $a AAI3087941
040 $a UnM $c UnM
100 1 $a McGovern, Susan Lynne. $3 1948951
245 1 0 $a Specificity and promiscuity among hits, leads, and drugs.
300 $a 230 p.
500 $a Source: Dissertation Abstracts International, Volume: 64-04, Section: B, page: 1724.
500 $a Adviser: Brian K. Shoichet.
502 $a Thesis (Ph.D.)--Northwestern University, 2003.
520 $a Specificity is key to the function of biologically active molecules, including messengers, hormones, and drugs. Perplexingly, many small-molecule enzyme inhibitors show poor specificity. To investigate the origins of inhibitor promiscuity, 110 compounds were studied. These compounds included hits from virtual and high-throughput screening, leads for drug design, and clinically-used drugs. Fifty of these compounds (35 hits, 8 leads, and 7 drugs) were found to inhibit diverse model enzymes, including beta-lactamase, chymotrypsin, dihydrofolate reductase, malate dehydrogenase, and beta-galactosidase. These promiscuous inhibitors acted in a time-dependent manner that was sensitive to enzyme concentration, ionic strength, and albumin. By light scattering and electron microscopy, promiscuous compounds were observed to form spherical particles of 30--1000 nm diameter. Particles were absent from solutions of the 60 non-promiscuous compounds (10 hits, 7 leads, and 43 drugs). Based on these observations, it was hypothesized that the promiscuous compounds formed aggregates in solution, and the aggregates inhibited the model enzymes. To explore the mechanism of aggregate-based inhibition, biophysical and microscopy studies were performed. Co-sedimentation experiments suggested a direct interaction between enzyme and aggregrates; by electron microscopy, enzyme molecules were observed to associate with the surface of aggregates. This interaction was prevented by Triton X-100, which reversed enzyme inhibition by promiscuous compounds but not by specific inhibitors. These studies suggest that inhibition by aggregate-forming promiscuous compounds results from the reversible adsorption of enzyme onto the surface of aggregates, although absorption of enzyme into the aggregate interior cannot be excluded. This dissertation also provides methods for the identification of aggregate-forming promiscuous compounds, which appear to be widespread.
520 $a In its final chapter, this dissertation returns to the problem of modeling specificity in molecular docking. To address the influence of receptor representation on virtual screening, a crystallographic ligand-bound (holo), crystallographic ligand-free (apo), and a homology modeled representation of each of ten different enzyme systems were used to screen a database of 96,000 small molecules. Each structure was evaluated for its ability to discriminate between ligands and decoys. In seven of ten systems, the holo structure provided the best discrimination; the apo representation was more successful if the holo form was overdetermined.
590 $a School code: 0163.
650 4 $a Chemistry, Biochemistry. $3 1017722
650 4 $a Health Sciences, Pharmacology. $3 1017717
650 4 $a Biophysics, General. $3 1019105
650 4 $a Chemistry, Pharmaceutical. $3 550957
690 $a 0487
690 $a 0419
690 $a 0786
690 $a 0491
710 2 0 $a Northwestern University. $3 1018161
773 0 $t Dissertation Abstracts International $g 64-04B.
790 1 0 $a Shoichet, Brian K., $e advisor
790 $a 0163
791 $a Ph.D.
792 $a 2003
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3087941